D.E. Shaw & Co
FBIO icon

D.E. Shaw & Co’s Fortress Biotech FBIO Stock Holding History

D.E. Shaw & Co’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-756
Closed -$17K – 3872
2019
Q2 		$17K Buy
+756
New +$19.4K ﹤0.01% 3622
2016
Q2 		– Sell
-1,325
Closed -$62K – 3376
2016
Q1 		$62K Sell
1,325
-1,398
-51% -$59K ﹤0.01% 3319
2015
Q4 		$114K Buy
+2,723
New +$114K ﹤0.01% 3658

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

D.E. Shaw & Co's FBIO Position: Q3 2019 in Review

D.E. Shaw & Co sold out of Fortress Biotech (FBIO) in Q3 2019, closing a stake of 756 shares — an estimated $17K sold.

D.E. Shaw & Co first reported a position in FBIO in Q4 2015 and held it in 3 quarters. The position peaked at $114K in Q4 2015. 49 funds tracked by Wall St. Rank hold FBIO as of Q3 2019.

  • D.E. Shaw & Co reported no remaining Fortress Biotech position as of Q3 2019 after selling out during the quarter.
  • D.E. Shaw & Co sold 756 Fortress Biotech shares in Q3 2019, an estimated $17K.
  • D.E. Shaw & Co first reported a position in Fortress Biotech in Q4 2015 and held it in 3 quarters.
  • D.E. Shaw & Co's Fortress Biotech position peaked at $114K in Q4 2015.
  • 49 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2019.

Based on D.E. Shaw & Co's 13F filing for Q3 2019, filed 14 Nov 2019.